abstract |
The invention relates to a chlorogenic acid compound and a compound stranguria treating tablet containing the same, wherein the 2 theta angle of a characteristic peak in an X-ray diffraction pattern obtained by measuring the chlorogenic acid compound by using Cu-K α rays comprises 4.6 +/-0.2 degrees, 16.2 +/-0.2 degrees, 17.7 +/-0.2 degrees, 18.4 +/-0.2 degrees, 19.7 +/-0.2 degrees, 20.5 +/-0.2 degrees, 21.6 +/-0.2 degrees, 22.8 +/-0.2 degrees, 25.6 +/-0.2 degrees, 26.1 +/-0.2 degrees and 30.7 +/-0.2 degrees. |